Curaleaf Holdings (CURLF) Interest Expenses (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Interest Expenses of $299.0 million for Q4 2025, up 110855.93% year-on-year from N/an in Q4 2024, and up 110855.93% on a QoQ basis from -$270000.0 in Q4 2024.

Curaleaf Holdings (CURLF) Interest Expenses (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Interest Expenses for 7 consecutive years, with $299.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Interest Expenses rose 110855.93% year-over-year to $299.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $299.0 million (up 6215.54% YoY) and the FY2025 annual result came in at $586.0 million, up 39.79% from the prior year.
  • Interest Expenses grew to $299.0 million in Q4 2025 per CURLF's latest filing, from -$270000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for CURLF reached as high as $299.0 million in Q4 2025 and fell as low as -$17.5 million in Q4 2022.
  • A 5-year average of $40.0 million and a median of $2.3 million in 2021 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2024 — Interest Expenses tumbled 100.36% — and 2025, when it jumped 110855.93%.
  • Year by year, Interest Expenses stood at $32.2 million in 2021, then sank by 154.45% to -$17.5 million in 2022, then jumped by 530.58% to $75.4 million in 2023, then slumped by 100.36% to -$270000.0 in 2024, then soared by 110855.93% to $299.0 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods registered $299.0 million, -$270000.0, and $5.0 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 944.51 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.77 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 2.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.21 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 590.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 299.04 Mn
Dec 31, 2025 299.04 Mn
Dec 31, 2024 -270,000.00
Dec 31, 2024 -270,000.00
Sep 30, 2024 5.01 Mn
Sep 30, 2024 5.01 Mn
Dec 31, 2023 75.42 Mn
Dec 31, 2023 75.42 Mn
Sep 30, 2023 892,000.00
Sep 30, 2023 892,000.00
Dec 31, 2022 -17.52 Mn
Dec 31, 2022 -17.52 Mn
Sep 30, 2022 3.74 Mn
Sep 30, 2022 3.74 Mn
Sep 30, 2021 32.17 Mn
Sep 30, 2021 32.17 Mn
Jun 30, 2021 937,000.00
Jun 30, 2021 937,000.00
Mar 31, 2021 332,000.00
Mar 31, 2021 332,000.00